Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Moderna, inc. save search
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Published: 2024-04-25 (Just crawled : 12:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
| Email alert
Add to watchlist
congress respiratory cytomegalovirus research global
Moderna and OpenAI Collaborate To Advance mRNA Medicine
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 2.93%
H: 0.22%
C: -1.98%
mrna
Moderna Announces Contract with Brazil to Supply 12.5 million COVID-19 Vaccines as Part of National Vaccination Campaign
Published: 2024-04-22 (Crawled : 13:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 1.36%
H: 2.57%
C: 1.62%
covid-19 contract million brazil
Moderna to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: -1.62%
first report financial results
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 1.46%
H: 3.2%
C: -0.41%
ABUS | $2.75 -0.36% 160
|
Health Technology
|
| O: 16.73%
H: 6.14%
C: 2.39%
patent construction biopharma ongoing
Phase 1/2 Interim Data on Moderna’s mRNA-3927, an Investigational mRNA Therapy for Propionic Acidemia, Published in Nature
Published: 2024-04-03 (Crawled : 19:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -0.59%
H: 2.09%
C: -1.74%
rna-3927 mrna therapy
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
vaccine trials
Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
BX | $123.78 -0.43% -0.08% 1.7M
|
Finance
|
| O: 1.27%
H: 1.14%
C: 1.07%
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
life influenza sciences collaboration program
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 1.29%
H: 0.0%
C: -3.93%
covid-19 vaccine positive trial results
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Published: 2024-03-19 (Crawled : 12:30) - prnewswire.com
OMGA | $2.33 -0.43% -0.21% 180K
|
|
| O: 0.0%
H: 1.42%
C: -2.56%
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: -1.57%
H: 1.48%
C: -1.37%
MCRB | $0.7295 -4.01% -4.18% 5.7M
|
Health Technology
|
| O: 0.22%
H: 12.36%
C: 6.11%
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -0.35%
H: 1.59%
C: 1.16%
FHTX | $5.21 0.97% 0.96% 110K
|
Health Technology
|
| O: -1.01%
H: 5.45%
C: 3.41%
DNLI | $15.56 -3.41% -3.6% 40
|
Health Technology
|
| O: -0.75%
H: 3.41%
C: 3.01%
companies
Moderna to Present at Upcoming Investor Conferences in March 2024
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -1.25%
H: 4.49%
C: 2.61%
MODERNA CELEBRATES CONSTRUCTION COMPLETION OF CANADIAN MRNA MANUFACTURING FACILITY
Published: 2024-02-23 (Crawled : 22:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 0.16%
H: 1.38%
C: -3.15%
mrna construction
Merck Announces Fourth-Quarter and Full-Year 2023 Financial Results
Published: 2024-02-01 (Crawled : 23:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: -4.37%
H: 0.0%
C: 0.0%
MRK | $127.0 0.1% 0.63% 5.7M
|
Health Technology
|
| O: 2.38%
H: 2.25%
C: 2.21%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -0.15%
H: 0.1%
C: -1.86%
HARP | $23.01 0.07% 6.6M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
merck financial results
Moderna to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 22, 2024
Published: 2024-02-01 (Crawled : 12:30) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -0.15%
H: 0.1%
C: -1.86%
report year financial results
Global mRNA-based Vaccines and Therapeutics Market is Projected to Grow Immensely During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-25 (Crawled : 23:00) - prnewswire.com
MTLHY | $29.93 -11.69% 1.1K
|
n/a
|
| O: -1.11%
H: 0.1%
C: 0.1%
SNYNF | News | $94.0 -0.27% -2.18% 310
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: -1.82%
VRTX | $400.76 -1.03% -1.06% 810K
|
Health Technology
|
| O: 0.25%
H: 0.27%
C: -0.2%
SLN | $22.27 -1.07% -0.81% 110K
|
Health Technology
|
| O: 4.32%
H: 0.0%
C: -3.68%
SNY | News | $46.61 -2.27% -2.21% 1.6M
|
Health Technology
|
| O: 0.5%
H: 0.0%
C: 0.0%
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 0.72%
H: 0.34%
C: -1.68%
MRUS | $41.97 2.82% 2.72% 740K
|
Health Technology
|
| O: 0.35%
H: 2.81%
C: -0.53%
ICLR | News | $309.44 0.98% 0.76% 960K
|
Health Technology
|
| O: 1.13%
H: 0.82%
C: -0.74%
BNTX | News | $88.09 -0.45% -0.35% 1.9K
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -0.83%
global therapeutics study market
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health's Advisory Board
Published: 2024-01-25 (Crawled : 13:00) - prnewswire.com
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 0.64%
H: 2.02%
C: 1.03%
Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Published: 2024-01-05 (Crawled : 17:00) - biospace.com/
OMGA | $2.33 -0.43% -0.21% 180K
|
|
| O: 1.41%
H: 0.37%
C: -18.55%
SANA | $8.58 6.06% 5.71% 1.2M
|
|
| O: 2.04%
H: 10.8%
C: 2.0%
MCRB | $0.7295 -4.01% -4.18% 5.7M
|
Health Technology
|
| O: 0.71%
H: 2.84%
C: -0.71%
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -0.82%
H: 7.46%
C: 3.11%
FHTX | $5.21 0.97% 0.96% 110K
|
Health Technology
|
| O: -1.79%
H: 7.65%
C: 2.55%
DNLI | $15.56 -3.41% -3.6% 40
|
Health Technology
|
| O: -2.47%
H: 0.66%
C: -2.18%
update fibrosis research
Moderna to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2023-12-20 (Crawled : 00:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -0.18%
H: 1.41%
C: -3.08%
conference
First In Vivo CAR-M Lead Candidate Nominated Under Carisma-Moderna Collaboration
Published: 2023-12-14 (Crawled : 12:00) - prnewswire.com
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: 12.56%
H: 7.3%
C: -2.94%
first candidate collaboration
Moderna Announces Changes to Commercial Organization to Prepare for Multiple Product Launches in 2024 and 2025
Published: 2023-12-12 (Crawled : 14:00) - biospace.com/
MRNA | News S | $108.85 0.89% 0.85% 3M
|
Health Technology
|
| O: -0.93%
H: 0.18%
C: -3.94%
commercial
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.